The Neural Crest and Cancer: a Developmental Spin on Melanoma
Overview
Cell Biology
Affiliations
Neural crest (NC) cells undergo an epithelial to mesenchymal transition (EMT) in order to exit from the dorsal neural tube. Similarly, ancestrally related melanoma cells employ an EMT-like event during the initial stages of metastasis to dissociate from surrounding keratinocytes. Whether or not the molecular pathogenesis and cellular dynamics of melanoma metastasis resemble the embryonic NC invasion program is unclear. Here, we highlight advances in our understanding of tumor cell behaviors and plasticity, focusing on the relationship between melanoma and the NC invasion programs. We summarize recent discoveries of NC cell guidance and emerging in vivo imaging strategies that permit single cell resolution of fluorescently labeled tumor cells, with a focus on our recently developed in vivo chick embryo transplant model. Crucial to the molecular pathogenesis of metastasis, we highlight advances in gene profiling of small cell numbers, including our novel ability to gather gene expression information during distinct stages of melanoma invasion. Lastly, we present preliminary details of a comparison of specific genetic pathways associated with the early phases of melanoma invasion and known NC induction and migration signals. Our results suggest that malignant melanoma cells hijack portions of the NC program to promote plasticity and facilitate metastasis. In summary, there is considerable power in combining an in vivo model system with molecular analysis of gene expression, within the context of established developmental signaling pathways, to identify and study the molecular mechanisms of metastasis.
Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy.
Shirley C, Chhabra G, Amiri D, Chang H, Ahmad N Front Immunol. 2024; 15:1336023.
PMID: 38426087 PMC: 10902921. DOI: 10.3389/fimmu.2024.1336023.
Inhibition of PANX1 Channels Reduces the Malignant Properties of Human High-Risk Neuroblastoma.
Langlois S, St-Pierre M, Holland S, Xiang X, Freeman E, Mohamed H J Cancer. 2023; 14(5):689-706.
PMID: 37056395 PMC: 10088893. DOI: 10.7150/jca.79552.
Rousset X, Maillet D, Grolleau E, Barthelemy D, Calattini S, Brevet M Cancers (Basel). 2022; 14(17).
PMID: 36077622 PMC: 9454737. DOI: 10.3390/cancers14174085.
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.
Diener J, Baggiolini A, Pernebrink M, Dalcher D, Lerra L, Cheng P Nat Commun. 2021; 12(1):5056.
PMID: 34417458 PMC: 8379183. DOI: 10.1038/s41467-021-25326-8.
Zhang A, Aslam H, Sharma N, Warmflash A, Fakhouri W Cells Tissues Organs. 2021; 210(3):151-172.
PMID: 34218225 PMC: 8387394. DOI: 10.1159/000516466.